Cannabis
Rosemary Mazanet, M.D., PhD. Joins Columbia Care’s Board of Directors – Medical Marijuana Program Connection
[ad_1]
NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and retailers of cannabis products in the U.S., today announced the transition of Rosemary Mazanet, M.D., PhD., from Chief Scientific Officer, a role she has held since 2017, to a member of the Company’s Board of Directors, effective immediately. Dr. Mazanet began advising Columbia Care in 2013 and then joined
[ad_2]
MMP News Author
Source link
